Constellation Pharmaceuticals INC
SEC CIK 1434418 · CNST · last insider filing 2021-07-23
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Hoerter Steven L. | Director | filed 2018 - 2021 |
| Goldsmith Mark A | Director | filed 2018 - 2021 |
| Levy Richard S | Director | filed 2020 - 2021 |
| Braunstein Scott | Director | filed 2019 - 2021 |
| Trehu Elizabeth | Director | filed 2018 - 2021 |
| Raythatha Jigar | Director · See Remarks | filed 2018 - 2021 |
| Audia James E | Director | filed 2018 - 2021 |
| Svennilson Peter | Director | filed 2018 - 2021 |
| Evnin Anthony B | Director | filed 2018 - 2019 |
| Tepper Robert I | Director | filed 2018 - 2019 |
| Chen Bihua | Director | filed 2018 - 2018 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Valentine Karen | See Remarks | filed 2018 - 2021 |
| Reeve Emma | Chief Financial Officer | filed 2018 - 2021 |
| Trojer Patrick | Chief Scientific Officer | filed 2018 - 2021 |
| Humphrey Jeffrey | Chief Medical Officer | filed 2020 - 2021 |
| Senderowicz Adrian | Chief Medical Officer | filed 2018 - 2020 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.